Home
Conditions
Myeloproliferative Neoplasm

Clinical trial condition

Myeloproliferative Neoplasm

Explore clinical trials studying Myeloproliferative Neoplasm. Study availability and eligibility vary by location and protocol.

112 public trials 37 recruiting studies

Refine in advanced search Browse all conditions

Myeloproliferative Neoplasm trial results

Not Yet Recruiting

Pacritinib With Aza for Upfront Myelodysplastic Syndrome

NCT07387354

Conditions: Bone Marrow Disease, Bone Marrow Diseases, Hematologic Diseases, +6 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Automated Total Marrow and Lymphoid Irradiation for Allogeneic Hematopoietic Cell Transplant

NCT07634536

Conditions: Acute Myeloid Leukemia, Bone Marrow Diseases, Hematologic Diseases, +9 more
Locations: Stanford University Palo Alto, California, United States

View Trial Details

Not Yet Recruiting

Efficacy and Safety of Ropeginterferon Alfa 2b (P1101) for Patients With Polycythemia Vera

NCT06290765

Conditions: Bone Marrow Diseases, Bone Marrow Neoplasms, Hematologic Diseases, +7 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Prevalence and Risk Factors of Pulmonary Hypertension in Patients with Myeloproliferative Neoplasms in Assiut University Hospital.

NCT06647706

Conditions: Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +2 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

A Prospective Patient Reported Outcomes and Wearables Study in Myeloproliferative Neoplasms

NCT06334913

Conditions: Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +2 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

MultiOmic characteriZation of Acute Myeloid Leukemia Evolving From myelopRoliferative Neoplasm to Identify New Targeted Therapeutic Strategies

NCT06022341

Conditions: Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +3 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Sequential and Personalized PK-guided Busulfan Administration in the Frame of the Conditiong Regimen for Allo-HSCT in Patients With Malignant Hemopathies Ineligible for the Standard Myeloablative Conditioning

NCT04451200

Conditions: Acute Leukemia, Bone Marrow Diseases, Hematologic Diseases, +4 more
Locations: Not specified

View Trial Details

Completed

Fedratinib in Myelodysplastic /Myeloproliferative Neoplasms (MDS/MPNs) and Chronic Neutrophilic Leukemia (CNL)

NCT05177211

Conditions: Bone Marrow Diseases, Chronic Disease, Chronic Neutrophilic Leukemia, +9 more
Locations: Moffitt Cancer Center Tampa, Florida, United States

University of Michigan Rogel Cancer Center Ann Arbor, Michigan, United States

Cleveland Clinic Cleveland, Ohio, United States

View Trial Details

Completed

Acquired Pyruvate Kinase Deficiency In Clonal Myeloid Neoplasms

NCT04902833

Conditions: Acute Myeloid Leukemia, Anemia, Anemia, Hemolytic, +24 more
Locations: Massachusetts General Hospital Boston, Massachusetts, United States

View Trial Details

Completed

Graft-Versus-Host Disease Prophylaxis in Treating Patients With Hematologic Malignancies Undergoing Unrelated Donor Peripheral Blood Stem Cell Transplant

NCT01231412

Conditions: Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Aggressive Non-Hodgkin Lymphoma, +58 more
Locations: University of Colorado Denver, Colorado, United States

Presbyterian - Saint Lukes Medical Center - Health One Denver, Colorado, United States

Emory University/Winship Cancer Institute Atlanta, Georgia, United States

Huntsman Cancer Institute/University of Utah Salt Lake City, Utah, United States

View Trial Details

Myeloproliferative Neoplasm

Myeloproliferative Neoplasm trial results

Related conditions